4//SEC Filing
Mack David Henry 4
Accession 0001209191-24-001993
CIK 0001699382other
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 4:02 PM ET
Size
12.5 KB
Accession
0001209191-24-001993
Insider Transaction Report
Form 4
Mack David Henry
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2024-01-18+519,915→ 519,915 totalExercise: $1.80Exp: 2034-01-18→ Common Stock (519,915 underlying) - Award
Common Stock
2024-01-18+163,890→ 442,460 total
Holdings
- 56,978(indirect: See footnote)
Common Stock
- 165,307(indirect: See footnote)
Common Stock
- 147,915(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 30, 2025.
- [F2]The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F3]The shares are held of record by The Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F4]Shares subject to the option vest in 48 equal monthly installments beginning on February 18, 2024.
Issuer
PMV Pharmaceuticals, Inc.
CIK 0001699382
Entity typeother
Related Parties
1- filerCIK 0001341642
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 4:02 PM ET
- Size
- 12.5 KB